Majority of the ALK gene translocation status are evaluated in primary tumours of NSCLC and in practice, most clinical decision-making for patients with advanced NSCLC depends on single-tumour biopsy samples from primary or metastatic sites, even from cytological specimens20, 21. The gene discussed is ALK; the disease is neoplasm.